Patent intelligence · US
US 6896909
Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders
Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders
Patent details — US 6896909
- Jurisdiction
- US
- Status
- expired
- Grant date
- May 24, 2005
- Expiration
- May 19, 2025
- Applicant
- WINMEDICAL S.R.L.
- Claims
- 16
- CPC classes
- A61K, A61K33/26, A61P, A61P17/00
Quick answer
US 6896909 (Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders) is held by WINMEDICAL S.R.L.. Status: expired. Granted May 24, 2005. Expires May 19, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- WINMEDICAL S.R.L.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K33/26, A61P, A61P17/00, A61P19/02, A61P29/00
More from WINMEDICAL S.R.L.
Related pharmaceutical patents in our USPTO index.
-
US 12357604
Topical formulations of cannabinoids and use thereof in the treatment of pain
granted -
US 12083229
Ocular drug delivery formulation
granted -
US 12042479
Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders
granted -
US 11472840
Acetylcholine receptor-binding peptide
granted -
US 11471534
Chitosan-pluronic complex and nano-carrier comprising same
granted -
US 8361485
Conditioned cell culture medium compositions and methods of use
granted -
US 8268336
Compositions containing aromatic aldehydes and their use in treatments
granted -
US 8246969
Compositions containing aromatic aldehydes and their use in treatments
granted
Frequently asked questions
What is US patent 6896909?
US 6896909 (Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders) is held by WINMEDICAL S.R.L.. Status: expired. Granted May 24, 2005. Expires May 19, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6896909?
WINMEDICAL S.R.L. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 15 pharmaceutical patents for this assignee.
When does US 6896909 expire?
Our index shows an expiration date of May 19, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.